Baseline amyloid and tau PET imaging characteristics in the ongoing phase 2 study of tilavonemab in early Alzheimer’s diseaseDustin W. Wooten,Qi Guo,Ziyi Jin,Scott Gladstein,Edwin Stage,Jacob Hesterman,Nahome Fisseha,Hana Florian,Robert A. ComleyAlzheimer's & Dementia(2021)引用 0|浏览5暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要